Literature DB >> 27057296

Case Report: Acute Cerebellar Thrombosis in an Adult Patient with IgM Nephropathy.

Abimbola Adike1, Mariyam Cherry1, Melina Awar1.   

Abstract

IgM nephropathy is a relatively rare cause of idiopathic nephrotic syndrome.1 It was initially described by van de Putte,2 then by Cohen and Bhasin in 1978, as a distinctive feature of mesangial proliferative glomerulonephritis.2 It is typically characterized by diffuse IgM deposits on the glomeruli and diffuse mesangial hypercellularity. Little is known about the pathogenesis and treatment of this disease.1,3 We describe a patient who presented with nonspecific symptoms of epigastric pain, nausea, and early satiety. Abdominal imaging and endoscopies were unremarkable. She was found to have significant proteinuria (6.4 g/24 hours), hyperlipidemia, and edema consistent with a diagnosis of nephrotic syndrome. Kidney biopsy was performed and confirmed an IgM nephropathy. Less than 2 weeks after her diagnosis of IgM nephropathy, she presented with an acute cerebellar stroke. Thrombophilia is a well-known complication of nephrotic syndrome, but a review of the literature failed to show an association between IgM nephropathy and acute central nervous system thrombosis.

Entities:  

Keywords:  IgM nephropathy; cerebellar thrombosis; thromboembolic events

Mesh:

Substances:

Year:  2015        PMID: 27057296      PMCID: PMC4814013          DOI: 10.14797/mdcj-11-4-247

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  13 in total

1.  IgM nephropathy; time to act.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2014-01-01

2.  Recurrent or persistent hematuria. Sign of mesangial immune-complex deposition.

Authors:  L B van de Putte; G B de la Riviere; P J van Breda Vriesman
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

3.  Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.

Authors:  Sean J Barbour; Allen Greenwald; Ognjenka Djurdjev; Adeera Levin; Michelle A Hladunewich; Patrick H Nachman; Susan L Hogan; Daniel C Cattran; Heather N Reich
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

4.  IgM nephropathy: clinical picture and pathological findings in 36 patients.

Authors:  Ghadeer A Mokhtar
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-09

Review 5.  Transient ischemic attack and nephrotic syndrome: Case report and review of literature.

Authors:  Shailesh S Nandish; Romesh Khardori; Elamin M Elamin
Journal:  Am J Med Sci       Date:  2006-07       Impact factor: 2.378

Review 6.  Prophylaxis of thromboembolic events in patients with nephrotic syndrome.

Authors:  Kathleen J Pincus; Lauren M Hynicka
Journal:  Ann Pharmacother       Date:  2013-04-23       Impact factor: 3.154

7.  High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.

Authors:  Bakhtawar K Mahmoodi; Min Ki ten Kate; Femke Waanders; Nic J G M Veeger; Jan-Leendert P Brouwer; Liffert Vogt; Gerjan Navis; Jan van der Meer
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

Review 8.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

Review 9.  Management of patients with nephrotic syndrome.

Authors:  S de Seigneux; P Y Martin
Journal:  Swiss Med Wkly       Date:  2009-07-25       Impact factor: 2.193

10.  IgM nephropathy revisited.

Authors:  Muhammed Mubarak; Javed I Kazi
Journal:  Nephrourol Mon       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.